§ 360bbb–6. Risk communication
236 words·~1 min read·
/usc/title-21/section-360bbb-6A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary shall establish an advisory committee to be known as the “Advisory Committee on Risk Communication” (referred to in this section as the “Committee”). The Committee shall advise the Commissioner on methods to effectively communicate risks associated with the products regulated by the Food and Drug Administration. The Secretary shall ensure that the Committee is composed of experts on risk communication, experts on the risks described in subsection (b), and representatives of patient, consumer, and health professional organizations.
Section 1013 of title 5 shall not apply to the Committee established under this subsection. The Secretary shall partner with professional medical societies, medical schools, academic medical centers, and other stakeholders to develop robust and multi-faceted systems for communication to health care providers about emerging postmarket drug risks. The systems developed under paragraph
(1)shall— account for the diversity among physicians in terms of practice, willingness to adopt technology, and medical specialty; and include the use of existing communication channels, including electronic communications, in place at the Food and Drug Administration. ( June 25, 1938, ch. 675, § 567 , as added Pub. L. 110–85, title IX, § 917 , Sept. 27, 2007 , 121 Stat. 960 ; amended Pub. L. 117–286, § 4(a)(157) , Dec. 27, 2022 , 136 Stat. 4323 .)
Connectionstraces to 1
3 references not yet in our index
- Pub. L. 110-85
- 121 Stat. 960
- 136 Stat. 4323
Citation graph
cites case law
§ 360bbb–6
Risk communication
Pub. L.Pub. L. 110-85
Stat.121 Stat. 960
Stat.136 Stat. 4323
Cites 4Cited by 0 across 0 sources